MedTrace Logo

Statin Eligibility Prior to Myocardial InfarCtion

NCT03485742 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 740

Last updated 2019-06-26

No results posted yet for this study

Summary

The study (Statin Eligibility Prior to myocardial infarction (MI) in Jordanians, StatinEPIC) is

1. Cross sectional
2. Non interventional
3. One encounter per patient. No follow up. It addresses a major issue of primary prevention in Jordanians especially the young population, namely the issue of lipid lowering agents before sustaining an acute MI. A recent study in USA showed that 50% of patients who sustained MI were not eligible to statins had they been evaluated before the heart attack. It is largely unknown if a larger percentage of Middle Eastern patients who sustain a heart attack would be eligible to receive lipid lowering agents.
4. The PI will overlook the whole process. Dr Ahmad Tamari, the assistant to the PI will asses this whole process of data collection, management and manuscript drafting.

Conditions

Interventions

OTHER

No intervention

No intervention. Collection of data on statin eligibility in patients admitted with MI

Sponsors & Collaborators

  • Jordan Collaborating Cardiology Group

    lead OTHER

Principal Investigators

  • Yasmine Obeidat, MS · Hashemmeyyeh University School of Medicine, Zarka, Jordan

  • Ayman J Hammoudeh, MD, FACC · Istishari Hospital, Department of Cardiology, Amman, Jordan

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-22
Primary Completion
2019-06-10
Completion
2019-06-10

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485742 on ClinicalTrials.gov